Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.
Shandong Xinhua Pharmaceutical Company Limited announced that it has received the Drug Registration Certificate for its Minoxidil Liniment from the National Medical Products Administration. This approval allows the company to market the product, which is used for treating male pattern baldness and alopecia areata, as an over-the-counter drug, potentially enhancing its market presence and offering new opportunities for growth.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, focusing on the production and distribution of pharmaceutical products. The company operates in the pharmaceutical industry, offering a range of products including over-the-counter drugs.
Average Trading Volume: 8,369,606
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.52B
See more data about 0719 stock on TipRanks’ Stock Analysis page.